Data

Imagery Rescripting of Mental Images of Suicide, A Feasibility Study

Orygen

Dataset description

This dataset includes information from a pilot study evaluating the acceptability, feasibility, and safety of Imagery Rescripting as a psychological intervention for young people with mood disorders and suicidal ideation. The dataset captures data from 25 participants who received 2-4 weekly, face-to-face therapy sessions focused on rescripting distressing mental images of suicide. It includes details on participant engagement, the number of sessions attended, the specific mental images targeted, and the outcomes related to suicidal ideation. The dataset also records clinician adherence to the intervention protocol and the support provided through supervision sessions.
Click to explore relationships graph

Subjects

FOR: Mental Health |

Source Study

Trial acronym

MISO-I

Trial ID

ACTRN12624000639527

Purpose

Treatment

Phase

Not Applicable

Funding

Charities/Societies/Foundations,Suicide Prevention Australia

Scientific enquiries

Prof Lianne Schmaal

Brief Summary

Suicide is the leading cause of death among Australians aged 15-24 . Increasing our understanding of risk factors and developing novel indicated interventions to reduce deaths by suicide is urgently needed. In this project, we aim to develop and test the acceptability, feasibility and safety of a novel psychological intervention for young people with suicidal thoughts, that specifically targets a distressing form of suicidal thoughts that has been underrecognized in both clinical practice and re ....
Read more

Key Inclusion Criteria

1. Young people aged 16 to 25 inclusive; 2. Current or recent suicidal ideation (within last 4 weeks); 3. Engagement with Orygen Specialist Program’s Youth Mood Clinic treatment as determined by the treating clinician; 4. Familiarity with, and willingness to use available crisis supports in context of suicide risk determined by patient report and clinical information; 5. Ability to provide informed consent and comply with study procedures; 6. Willingness to nominate an emergency contact; 7. Repo ....
Read more

Key Exclusion Criteria

1. Presence of an intellectual disability as documented on their medical record; 2. Not able to converse in, or read in English; 3. Poorly engaged in face-to-face treatment or approaching discharge as determined by the treating clinician; 4. Currently at acute risk of suicide requiring acute risk management; 5. Actively manic or psychotic (assessed by treating clinician) as assessed by the treating clinician; 6. Active mania or psychosis as assessed by the treating clinician; 7. Has not experien ....
Read more

Can healthy volunteers participate?

No

 

Population

Sample Size    25

Min. age    16 Years

Max. age    25 Years

Sex    Both males and females

Condition category    Depression , Suicide , mental health

Condition code    Mental Health

Intervention

Intervention code Behaviour

This study will test the acceptability, feasibility and safety of a novel intervention (Imagery Rescripting) in a small pilot study of 25 young people with mood disorders and suicidal ideation from the Youth Mood Clinic (YMC), at Orygen Specialist Programs. Young people with Depression will receive Imagery Rescripting treatment following the study protocol for treating mental images of suicide in youth with mood disorders. Study clinicians are experienced psychologists in the YMC and are trained ....
Read more

Comparison

Control group Uncontrolled

No control group. This is a feasibility and acceptability study.

Outcomes

Outcome: Acceptability
Timepoint: Final assessment - week 7 post enrolment /conclusion of intervention

Outcome: Feasibility
Timepoint: Conclusion of recruitment period, 2 years

Outcome: Safety
Timepoint: Baseline, each imagery rescripting session (weekly from week 2 up to week 6), Final assessment at Week 7/conclusion of intervention.

Study Protocol: Not Available
Data Dictionary: Not Available

Will individual participant data (IPD) for this trial be available?

yes

What data in particular will be shared?

All data, anonymised.

When will data be available?

Data are currently embargoed. They will be available after the main results have been published for an indefinite time.

Available to whom?

Data will potentially be available to researchers from not-for profit organisations, commercial organisations or other based in any location. All data requests will be considered by the data custodian and the primary sponsor on a case-by-case basis. Requests must include a methodologically sound proposal.

Available for what types of analyses?

To any type of analyses. Assessed on a case-by-case basis. Specific conditions of use may apply and will be specified in a data sharing agreement (or similar) that the requester must agree to before access is granted. For further information, see Orygen data management policy.

Source study information is derived from the Australian New Zealand Clinical Trials Registry (ANZCTR). For more information on the ANZCTR, please see anzctr.org.au